RxDoctor Payments Data

Shawn Ward, DPM

Podiatrist · Lima, OHNPI 1114923398

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,523 of the $12,416 with a category attached, or 68.6%. It is spread thinly across 37 manufacturers, the largest accounting for just 20.3%. Among podiatrist clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,416in general payments, 2019–2025

Across 159 payments — averaging $78.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$3K
  • Arteriocyte Medical Systems, Inc.$2K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • Paragon 28, Inc.$908
  • Smith+Nephew$762
  • Johnson & Johnson$650
  • plus $4K from 31 others

What the payments were for

  • Consulting fees$490%
  • Travel & lodging$3,81331%
  • Food & beverage$8,52369%
  • Gifts$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,416 in reported general payments places this provider in the 90th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio

Medicare billing

Part B allowed, 2024
$114,709
Medicare patients
252
Services billed
1,232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban20$10,536
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen65$559
Terbinafine Hcl42$436
Gabapentin18$283
Doxycycline Hyclate33$212
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$186
Clindamycin Hcl27$151
Triamcinolone Acetonide20$131
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$123
Cephalexin13$77
Ciprofloxacin Hcl15$71
Hydroxyzine Pamoate23$70
Tramadol Hcl19$36
Prednisone14$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$650$10,53620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 397 podiatrist providers in Ohio.

Other podiatrist in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →